home All News open_in_new Full Article

BB Biotech rutscht zum Start ins neue Jahr wieder in die Verlustzone

Biotechnologie - BB Biotech ist beim Start ins Jahr 2025 wieder tief in die Verlustzone gerutscht. Die Portfoliokonzentration nimmt zu.


today 16 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 247244208
Add Watch Country

arrow_drop_down